Diamonds in the rough The diamond industry is at a crossroads; Demand is projected to rise 3 per cent to 5 per cent per year, ...
Eli Lilly’s experimental drug lepodisiran has shown a 94% reduction in lipoprotein(a) levels, a key genetic risk factor for ...